<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T01:42:39Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10792787" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10792787</identifier>
        <datestamp>2024-01-17</datestamp>
        <setSpec>bmcph</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">BMC Public Health</journal-id>
              <journal-id journal-id-type="iso-abbrev">BMC Public Health</journal-id>
              <journal-title-group>
                <journal-title>BMC Public Health</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1471-2458</issn>
              <publisher>
                <publisher-name>BioMed Central</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10792787</article-id>
              <article-id pub-id-type="pmcid">PMC10792787</article-id>
              <article-id pub-id-type="pmc-uid">10792787</article-id>
              <article-id pub-id-type="pmid">38233908</article-id>
              <article-id pub-id-type="publisher-id">17538</article-id>
              <article-id pub-id-type="doi">10.1186/s12889-023-17538-y</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Study Protocol</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>A randomized controlled trial of the dissemination of an mHealth intervention for improving health outcomes: the WiseApp for Spanish-speakers living with HIV study protocol</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Olaya</surname>
                    <given-names>Felix</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Brin</surname>
                    <given-names>Maeve</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Caraballo</surname>
                    <given-names>Pamela Baez</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Halpern</surname>
                    <given-names>Mina</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Jia</surname>
                    <given-names>Haomiao</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ramírez</surname>
                    <given-names>Sergio Ozoria</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Padilla</surname>
                    <given-names>Janeth Juarez</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Stonbraker</surname>
                    <given-names>Samantha</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Schnall</surname>
                    <given-names>Rebecca</given-names>
                  </name>
                  <address>
                    <email>rb897@cumc.columbia.edu</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00hj8s172</institution-id><institution-id institution-id-type="GRID">grid.21729.3f</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8729</institution-id><institution>School of Nursing, </institution><institution>Columbia University, </institution></institution-wrap>560 W 168th St, New York, NY 10032 USA </aff>
                <aff id="Aff2"><label>2</label>Clínica de Familia La Romana, La Romana, Dominican Republic </aff>
                <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.137628.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8753</institution-id><institution>NYU Steinhardt School of Culture, </institution></institution-wrap>Education, and Human Development, New York, NY 10003 USA </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.137628.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8753</institution-id><institution>NYU School of Medicine, </institution></institution-wrap>New York, NY 10016 USA </aff>
                <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03wmf1y16</institution-id><institution-id institution-id-type="GRID">grid.430503.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 0703 675X</institution-id><institution>University of Colorado College of Nursing, Anschutz Medical Campus, </institution></institution-wrap>Aurora, CO 80045 USA </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>17</day>
                <month>1</month>
                <year>2024</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>17</day>
                <month>1</month>
                <year>2024</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2024</year>
              </pub-date>
              <volume>24</volume>
              <elocation-id>201</elocation-id>
              <history>
                <date date-type="received">
                  <day>12</day>
                  <month>9</month>
                  <year>2023</year>
                </date>
                <date date-type="accepted">
                  <day>19</day>
                  <month>12</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2024</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Background</title>
                  <p id="Par1">While there is no cure for HIV, adherence to antiretroviral therapy can extend the lifespan and improve the quality of life of people with HIV. Despite the global reduction of HIV infection rates in recent years, New York City and La Romana, Dominican Republic, continue to report high infection rates among Latino populations. Many people with HIV remain virally unsuppressed in these geographic hotspots, suggesting a need for additional interventions to overcome medication adherence barriers. Tailored and culturally appropriate mobile health (mHealth) technology can be an engaging way to improve adherence. The primary objective of this trial is to test the effectiveness of an mHealth tool to improve HIV medication adherence among Spanish-speaking people living in New York City and the Dominican Republic.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p id="Par2">The WiseApp study is a two-arm randomized controlled trial among 248 people with HIV across the New York and Dominican Republic sites over the course of 12 months. Participants are randomly assigned to either receive a CleverCap pill bottle that is linked to the WiseApp (intervention) or standard of care (control). All participants complete surveys at baseline, 3-month, 6-month, and 12-month follow-up visits and the study team obtains HIV-1 viral load and CD4 count results through blood draw at each study timepoint.</p>
                </sec>
                <sec>
                  <title>Discussion</title>
                  <p id="Par3">The use of mHealth technologies to improve medication adherence among people with HIV has been implemented in recent years. Although some studies have found improvement in adherence to antiretroviral therapy in the short term, there is limited information about how these interventions improve adherence among Spanish-speaking populations. Disproportionate rates of HIV infection among Latinos in New York City suggest an existing inequitable approach in reaching and treating this population. Due to a lack of mHealth studies with Latino populations, and apps tailored to Spanish-speakers, the WiseApp study will not only demonstrate the effectiveness of this particular mHealth app but will also contribute to the mHealth research community as a whole.</p>
                </sec>
                <sec>
                  <title>Trial registration</title>
                  <p id="Par4">This trial was registered with Clinicaltrials.gov (NCT05398185) on 5/31/2022.</p>
                </sec>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>Medication adherence</kwd>
                <kwd>People with HIV (PWH)</kwd>
                <kwd>Antiretroviral therapy (ART)</kwd>
                <kwd>Mobile Health (mHealth)</kwd>
                <kwd>Spanish speakers</kwd>
                <kwd>Latinos</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000133</institution-id>
                      <institution>Agency for Healthcare Research and Quality</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R18HS028523</award-id>
                  <award-id>R18HS028523</award-id>
                  <award-id>R18HS028523</award-id>
                  <award-id>R18HS028523</award-id>
                  <award-id>R18HS028523</award-id>
                  <award-id>R18HS028523</award-id>
                  <award-id>R18HS028523</award-id>
                  <award-id>R18HS028523</award-id>
                  <award-id>R18HS028523</award-id>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© BioMed Central Ltd., part of Springer Nature 2024</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <title>Background</title>
              <p id="Par15">Thirty nine million people are currently living with HIV across the globe [<xref ref-type="bibr" rid="CR1">1</xref>]. While there is no cure for HIV, antiretroviral therapy (ART) can be taken as a daily oral medication, or through longer-acting injections to suppress HIV replication to undetectable levels [<xref ref-type="bibr" rid="CR2">2</xref>]. People with HIV (PWH) who adhere to their prescribed ART regimen can live a long, healthy life [<xref ref-type="bibr" rid="CR2">2</xref>]. Despite the efficacy of ART, PWH must take their medication as prescribed to properly manage their HIV.</p>
              <p id="Par16">Although HIV infection rates have decreased globally throughout the past two decades, prevalence rates remain high in certain geographic hotspots [<xref ref-type="bibr" rid="CR3">3</xref>]. Two settings, New York City (NYC) and La Romana, Dominican Republic (DR), are high priority areas in the US [<xref ref-type="bibr" rid="CR4">4</xref>] and the Caribbean [<xref ref-type="bibr" rid="CR5">5</xref>]. The DR has one of the highest rates of HIV infections in the Caribbean with approximately 79,000 PWH [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Haiti, with whom DR shares territory on the island of Hispaniola, reports the highest rate in the region [<xref ref-type="bibr" rid="CR8">8</xref>]. Despite increased accIn the proposed study
, we are leveraging a mHealth tool (Wiseess to ART in recent years in the DR, only about 63% of people who have been diagnosed with HIV are taking ART and only 52% have achieved viral suppression (48% virally unsuppressed) [<xref ref-type="bibr" rid="CR6">6</xref>]. These percentages are lower than in NYC where 84% of PWH have been prescribed ART and 79% are virally suppressed (21% virally unsuppressed) [<xref ref-type="bibr" rid="CR9">9</xref>]. Regardless, additional interventions are needed to help PWH manage this disease and overcome barriers to achieving viral suppression in both locations. The most recent (2021) NYC HIV/AIDS surveillance report found that of the current 129,660 PWH in NYC, 33.4% self-reported their ethnicity as Latino/Hispanic [<xref ref-type="bibr" rid="CR9">9</xref>]. This data shows a disproportionate rate of infections among the Latino population as only 28.9% of the total NYC population identifies as Latino [<xref ref-type="bibr" rid="CR10">10</xref>].</p>
              <p id="Par17">PWH face several barriers to achieving and maintaining medication adherence such as substance use, depression, daily life events, missing refills, side effects, and cost of transportation/medications among others [<xref ref-type="bibr" rid="CR11">11</xref>]. Mobile health (mHealth) interventions present an equitable solution to receiving tailored care for managing a chronic disease [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Although the use of mHealth interventions in DR is still in the early stages of implementation [<xref ref-type="bibr" rid="CR14">14</xref>], studies have found that 87.6% of people living in the DR own a cellphone [<xref ref-type="bibr" rid="CR15">15</xref>] with 84% of people of the overall population of the Caribbean owning a smartphone [<xref ref-type="bibr" rid="CR16">16</xref>], suggesting a high rate of smartphone users in the DR. Meanwhile, a recent study demonstrated that 85% of the United States (US) population owns a smartphone [<xref ref-type="bibr" rid="CR17">17</xref>], with similar rates estimated in NYC [<xref ref-type="bibr" rid="CR18">18</xref>]. High smartphone penetration allows for widespread use of mHealth interventions across diseases and populations.</p>
              <p id="Par18">In the proposed study, we are leveraging a mHealth tool (WiseApp) [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>] to test the effectiveness of a smart pill bottle, called the CleverCap, which is an electronic pill bottle that connects via Bluetooth to a medication adherence app (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Through formative work with expert panels, cognitive interviews and usability testing [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>], we translated the WiseApp into Spanish and tested it among end-users to refine content to meet the needs of Spanish-speaking Latino/Hispanic PWH in NYC and the DR. Similar studies have been conducted by the study team in NYC [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>], however, recruitment did not specifically target Spanish-speakers, and to date, few mHealth interventions have been tested among Spanish-speakers [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. The objective of this paper is to detail the procedures used for a randomized controlled trial (RCT) which began recruitment in March of 2023.</p>
              <p id="Par19">
                <fig id="Fig1">
                  <label>Fig. 1</label>
                  <caption>
                    <p>The WiseApp</p>
                  </caption>
                  <graphic xlink:href="12889_2023_17538_Fig1_HTML" id="MO1"/>
                </fig>
              </p>
            </sec>
            <sec id="Sec2">
              <title>Methods</title>
              <sec id="Sec3">
                <title>Study design</title>
                <p id="Par20">This study is a 12-month RCT among Spanish-speaking PWH living in NYC and the DR. Participants are randomized to either receive a CleverCap pill bottle that is linked to the WiseApp (Arm 1), or standard health services offered at each site and a brief adherence educational session (Arm 2). Regardless of randomization, all participants schedule baseline, 3-, 6-, and 12-month visits. Each visit includes taking blood samples (HIV-1 viral load and CD4 counts) and completing an online survey in Spanish. Participants in both arms receive referrals to mental health counseling, drug/alcohol treatment, and/or other HIV services as necessary.</p>
              </sec>
              <sec id="Sec4">
                <title>Recruitment and eligibility</title>
                <p id="Par21">Participants are recruited primarily through direct outreach at the Comprehensive Health Program Adult Services Clinic in the New York-Presbyterian (NYP) Hospital in Washington Heights for the NYC site and at the Clínica de Familia La Romana in La Romana for the DR site. Additional targeted recruitment in NYC occurs through snowball sampling [<xref ref-type="bibr" rid="CR27">27</xref>], online advertisements, and the distribution of flyers at HIV clinics and community-based organizations with services for PWH and the LGBTQ community. All verbal and written communication during the recruitment process is in Spanish. Those recruited through targeted recruitment are directed to an online web survey via Research Electronic Data Capture (REDCap) for eligibility screening. Eligibility is confirmed through screening in-person or over the phone. In order to be eligible, participants must: (1) speak, read, and write in Spanish; (2) be 18 years or older; (3) be willing to participate in any assigned arm; (4) have an HIV diagnosis of ≥ 6 months ago; (5) have an HIV-1 RNA level &gt; 50 copies/mL; (6) have a viral load &gt; 50; (7) own a smartphone; and (8) provide informed consent for study participation and access to medical records. Participants are not eligible if they: (1) reside in a nursing home, prison, and/or are receiving in-patient psychiatric care at the time of enrollment; (2) have a terminal illness with life expectancy less than six months; (3) plan to move out of the area (NYC or DR) in the next 12 months; (4) have a cognitive state minimum score of 24 measured by the Mini-Mental State Examination (MMSE) [<xref ref-type="bibr" rid="CR28">28</xref>] to ensure participants are oriented to the time and place; and/or (5) have another family/household member who is already enrolled in the study due to study contamination [<xref ref-type="bibr" rid="CR29">29</xref>].</p>
              </sec>
              <sec id="Sec5">
                <title>Ethics</title>
                <p id="Par22">All study procedures were approved by the Columbia University Institutional Review Board (IRB) and the Consejo Nacional de Bioética en Salud (CONABIOS), the ethical review committee in the DR, prior to recruitment and enrollment of study participants. Participants review the Informed Consent Form with a study team member and sign consent through REDCap before starting any baseline procedures.</p>
              </sec>
              <sec id="Sec6">
                <title>Sample size calculation</title>
                <p id="Par23">A power analysis was calculated to ensure that the sample size detects at least a medium effect size of the difference in adherence to ART at 3, 6, and 12 months between study arms. We estimated statistical power based on a previous mHealth study where results showed that adherence to ART was higher in the intervention compared to the control arm (0.565 vs. 0.460, that is in the small effect size range) and a Pearson correlation coefficient of adherence of 0.6 between consecutive study times [<xref ref-type="bibr" rid="CR30">30</xref>]. Using two-sided tests for generalized linear mixed model, we have at least 80% power to test for such differences by site based on these assumptions: (1) target enrollment is 248 participants across sites randomized to each study arm; (2) outcomes are measured at each follow-up visit; and (3) an overestimate of 10% attrition at 3 months and 20% at 6 and 12 months. The sample size at each site does not have enough statistical power to detect a small effect size of difference between the two arms at each follow-up time, but it is enough to test for a medium effect size of difference or greater between the two arms at 3, 6, and 12 months, separately, or to test for a small effect size of difference during entire follow-up period with &gt; 80% statistical power.</p>
              </sec>
              <sec id="Sec7">
                <title>Randomization</title>
                <p id="Par24">Informed consent is obtained at the baseline visit and study participants are randomized to study arms in a 1:1 ratio of 1 - Intervention (arm 1: WiseApp and CleverCap) and 1 - Control (arm 2: standard of care), stratified by site (NYC and DR). Participants are randomized using computer-generated random numbers at baseline and are assigned to one of two trial arms using sequentially numbered, opaque, sealed envelopes containing the intervention assignment, which the staff member opens at the moment of randomization [<xref ref-type="bibr" rid="CR31">31</xref>].</p>
              </sec>
              <sec id="Sec8">
                <title>Description of the intervention: WiseApp</title>
                <p id="Par25">The WiseApp is an mHealth app [<xref ref-type="bibr" rid="CR32">32</xref>–<xref ref-type="bibr" rid="CR34">34</xref>] culturally adapted for Latinos and translated to Spanish through a rigorous iterative community participatory feedback process with the goal of helping PWH adhere to their ART medication regimen. The app is connected to the CleverCap, a smart pill bottle that automatically senses when the bottle is opened and closed, which then records that the user took their medication for the day on the graph within their app account. Participants add their ART to the CleverCap pill bottle at their baseline appointment. Within the app, there are medication reminders and tracking features to set a medication dosing schedule and view adherence statistics. Study participants can also communicate with study staff through the chat feature. The study team is able to view users’ medication adherence statistics through an online portal. More specifically, the study team can view if the participant took their medication on time, off schedule, or if they did not take it. Medication adherence data collected through use of the CleverCap is analyzed upon completion of the study.</p>
              </sec>
              <sec id="Sec9">
                <title>Study assessments</title>
                <p id="Par26">All participants are enrolled on-site at NYP in NYC or Clínica de Familia La Romana, in the DR so that they can complete a blood draw to obtain HIV-1 viral load and CD4 count results at each study timepoint (baseline, 3-, 6-, and 12-months). Participants also complete a survey at all 4 visits. All study materials and visits are completed in Spanish. Surveys are administered through REDCap and are used to collect data on demographics, quality of life, HIV symptoms [<xref ref-type="bibr" rid="CR35">35</xref>], engagement in HIV care [<xref ref-type="bibr" rid="CR36">36</xref>], HIV-related stigma [<xref ref-type="bibr" rid="CR37">37</xref>], alcohol and substance use [<xref ref-type="bibr" rid="CR38">38</xref>], and depression and anxiety [<xref ref-type="bibr" rid="CR39">39</xref>–<xref ref-type="bibr" rid="CR42">42</xref>]. ART adherence is measured through self-report [<xref ref-type="bibr" rid="CR43">43</xref>] and use of the WiseApp and CleverCap bottle. The differences in study arms are presented in Table <xref rid="Tab1" ref-type="table">1</xref>.</p>
                <p id="Par27">
                  <table-wrap id="Tab1">
                    <label>Table 1</label>
                    <caption>
                      <p>Intervention v. control procedures and measures</p>
                    </caption>
                    <table frame="hsides" rules="groups">
                      <thead>
                        <tr>
                          <th align="left"/>
                          <th align="left">Baseline</th>
                          <th align="left">3-Month Follow-Up</th>
                          <th align="left">6-Month Follow-Up</th>
                          <th align="left">12-Month Follow-Up</th>
                        </tr>
                        <tr>
                          <th align="left" colspan="5">Intervention</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left"> Survey and measures</td>
                          <td align="left">X</td>
                          <td align="left">X</td>
                          <td align="left">X</td>
                          <td align="left">X</td>
                        </tr>
                        <tr>
                          <td align="left"> WiseApp &amp; CleverCap</td>
                          <td align="left"/>
                          <td align="left">X</td>
                          <td align="left">X</td>
                          <td align="left">X</td>
                        </tr>
                        <tr>
                          <td align="left">
                            <p> Primary Outcome:</p>
                            <p>ART adherence (SRSI)<sup>a</sup> [<xref ref-type="bibr" rid="CR43">43</xref>]</p>
                          </td>
                          <td align="left">X</td>
                          <td align="left">X</td>
                          <td align="left">X</td>
                          <td align="left">X</td>
                        </tr>
                        <tr>
                          <td align="left">
                            <p> Secondary Outcomes:</p>
                            <p>Viral Load/CD4 count through blood draw</p>
                          </td>
                          <td align="left">X</td>
                          <td align="left">X</td>
                          <td align="left">X</td>
                          <td align="left">X</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="5">
                            <bold>Control</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left"> Survey and measures</td>
                          <td align="left">X</td>
                          <td align="left">X</td>
                          <td align="left">X</td>
                          <td align="left">X</td>
                        </tr>
                        <tr>
                          <td align="left"> Standard of care</td>
                          <td align="left"/>
                          <td align="left">X</td>
                          <td align="left">X</td>
                          <td align="left">X</td>
                        </tr>
                        <tr>
                          <td align="left">
                            <p> Primary Outcome:</p>
                            <p>ART adherence (SRSI) [<xref ref-type="bibr" rid="CR43">43</xref>]</p>
                          </td>
                          <td align="left"/>
                          <td align="left">X</td>
                          <td align="left">X</td>
                          <td align="left">X</td>
                        </tr>
                        <tr>
                          <td align="left">
                            <p> Secondary Outcomes:</p>
                            <p>Viral Load/CD4 count through blood draw</p>
                          </td>
                          <td align="left">X</td>
                          <td align="left">X</td>
                          <td align="left">X</td>
                          <td align="left">X</td>
                        </tr>
                      </tbody>
                    </table>
                    <table-wrap-foot>
                      <p><sup>a</sup>Self-report scale item</p>
                    </table-wrap-foot>
                  </table-wrap>
                </p>
                <sec id="Sec10">
                  <title>Primary and secondary outcomes</title>
                  <p id="Par28"> The primary outcome is improvement in ART adherence at 3, 6, and 12 months for those randomized to the WiseApp and CleverCap (intervention arm) as compared to the control arm. Measures for ART adherence include: (1) ART adherence (SRSI) [<xref ref-type="bibr" rid="CR43">43</xref>]; (2) the CleverCap adherence index, which is calculated as the number of unique days that CleverCap indicates either was “Taken” or “Improperly Closed” divided by the number of days during the assessment period; and (3) viral load. The secondary outcome for participants randomized to the intervention arm is (a) improved health-related quality of life; (b) decreased symptom burden; (c) improved engagement with healthcare providers; (d) decreased HIV-related stigma as compared to the control arm; and (e) changes in viral load and CD4 counts using bloods samples taken during study visits. The Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) flow diagram for the schedule of enrollment, interventions, and assessments of the study are presented in Fig. <xref rid="Fig2" ref-type="fig">2</xref>.</p>
                  <p id="Par29">
                    <fig id="Fig2">
                      <label>Fig. 2</label>
                      <caption>
                        <p>SPIRIT flow diagram for the schedule of enrollment, interventions, and assessments</p>
                      </caption>
                      <graphic xlink:href="12889_2023_17538_Fig2_HTML" id="MO2"/>
                    </fig>
                  </p>
                </sec>
              </sec>
              <sec id="Sec11">
                <title>Statistical analysis</title>
                <p id="Par30">Study participants from NYC and DR may be different; therefore, the analyses will be conducted separately for each site as well as for the total data from both sites. Intervention and control arms will be described with respect to baseline characteristics (e.g., means, standard deviations, ranges, and proportions). We will check for outliers, examine patterns of missing data, and conduct evaluation of deviations from normality for all outcomes to determine the need for transformations of variables or special analytic techniques. All multivariate analyses will be preceded by standard descriptive bivariate analyses to describe key variables and relationships among them. These analyses will include means, frequency tables, histograms, and examination of distributions. Following the guidelines issued by the European Medicines Agency [<xref ref-type="bibr" rid="CR44">44</xref>], we will not adjust for baseline differences in demographic characteristics when comparing the main outcomes between the intervention and control groups. Analyses will be based on linear or generalized linear mixed models. Inferences from mixed models are valid under the missing at random (MAR) assumption (i.e., missingness can be fully accountable by variables where there is complete information) with full-information maximum likelihood (FIML) estimation [<xref ref-type="bibr" rid="CR45">45</xref>]. These analyses will be complemented with assessment of how sensitive the inferences are to the MAR assumptions. Sensitivity analysis will be performed based on selection models for dropout [<xref ref-type="bibr" rid="CR46">46</xref>–<xref ref-type="bibr" rid="CR48">48</xref>]. All analyses will use the Intention-to-Treat principle [<xref ref-type="bibr" rid="CR49">49</xref>], which requires subjects’ data to be analyzed as randomized regardless of whether or not they used the WiseApp. We will assess for any significant differences in clinical factors (e.g., years since diagnosis, co-morbid conditions), since there is evidence that these clinical factors are related to our primary outcome [<xref ref-type="bibr" rid="CR50">50</xref>–<xref ref-type="bibr" rid="CR52">52</xref>]. All statistical tests will be two-sided tests with the level of significance at 0.05.</p>
              </sec>
            </sec>
            <sec id="Sec12" sec-type="discussion">
              <title>Discussion</title>
              <p id="Par31">Many mHealth interventions for medication adherence among PWH have been tested in recent years within the US [<xref ref-type="bibr" rid="CR53">53</xref>–<xref ref-type="bibr" rid="CR65">65</xref>] and abroad [<xref ref-type="bibr" rid="CR66">66</xref>–<xref ref-type="bibr" rid="CR77">77</xref>]. Past studies have identified usability, acceptability and feasibility of mHealth designed for PWH [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>] and some have demonstrated efficacy in improving adherence to ART in the short-term [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>]. Among mHealth interventions for PWH in the US, limited studies have recruited or plan to recruit Latino populations specifically [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR53">53</xref>–<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. An additional limitation to these studies is that of the study samples that included Latino participants, few offered the intervention to those whose first language is Spanish (or, in other words, eligibility criteria includes only English-speakers) [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. As for the Dominican Republic, there have been very few published health interventions for PWH in recent years [<xref ref-type="bibr" rid="CR78">78</xref>–<xref ref-type="bibr" rid="CR80">80</xref>] and more research is needed to identify acceptability of mHealth in low- and middle-income countries [<xref ref-type="bibr" rid="CR81">81</xref>].</p>
              <p id="Par32">It is estimated that the DR only provides treatment to about 52% of PWH [<xref ref-type="bibr" rid="CR82">82</xref>], meaning that alternative solutions are needed to ensure that PWH receive continued care to manage their disease. Some factors that affect HIV infection in the DR include poverty, lack of access to healthcare and prevention services, literacy, lack of information on sexuality and HIV/AIDS, and cultural barriers to preventive measures for HIV [<xref ref-type="bibr" rid="CR7">7</xref>]. mHealth allows for PWH to receive a healthcare intervention on a regular basis when they are unable to see a provider. High smartphone penetration in the DR allows for PWH to engage in mHealth interventions which are well-suited to their needs.</p>
              <p id="Par33">While smartphones are widely used in the US and DR, technology literacy may differ among users, for example, among different age groups. The WiseApp is a simple mHealth application that is to be used primarily to communicate with study staff or view adherence statistics with the purpose of helping PWH take their ART as prescribed. It was created and refined to be a highly usable app for all Spanish-speaking PWH, applying a “Broadcast Spanish” translation, thus avoiding use of colloquial phrases. With the added technology of the CleverCap smart pill bottle, which functions much like a regular pill bottle, participants can easily respond to reminders to take their medication. The WiseApp in Spanish has the potential to reach populations that have been excluded from past interventional studies as well as address disproportionate health outcomes among Latino identifying people.</p>
              <p id="Par34">The WiseApp in Spanish is intended to help PWH better manage their chronic disease by encouraging patients to adhere to a medication dosing schedule. Because of the negative health outcomes which may result from remaining virally unsuppressed, it is crucial that interventions address the specific needs of the target population (Spanish-speaking PWH). Disproportionate rates of HIV infection among Latinos in NYC suggest an existing inequitable approach in reaching and treating this population. Due to a lack of mHealth studies with Latino populations, and apps tailored to Spanish-speakers, the WiseApp study will not only demonstrate the effectiveness of this particular mHealth app, but will also contribute to the mHealth research community as a whole.</p>
            </sec>
          </body>
          <back>
            <glossary>
              <title>Abbreviations</title>
              <def-list>
                <def-item>
                  <term>PWH</term>
                  <def>
                    <p id="Par5">People with HIV</p>
                  </def>
                </def-item>
                <def-item>
                  <term>ART</term>
                  <def>
                    <p id="Par6">Antiretroviral therapy</p>
                  </def>
                </def-item>
                <def-item>
                  <term>NYC</term>
                  <def>
                    <p id="Par7">New York City</p>
                  </def>
                </def-item>
                <def-item>
                  <term>DR </term>
                  <def>
                    <p id="Par8">Dominican Republic</p>
                  </def>
                </def-item>
                <def-item>
                  <term>RCT</term>
                  <def>
                    <p id="Par9">Randomized controlled trial</p>
                  </def>
                </def-item>
                <def-item>
                  <term>NYP</term>
                  <def>
                    <p id="Par10">New York-Presbyterian</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MMSE</term>
                  <def>
                    <p id="Par11">Mini-Mental State Examination</p>
                  </def>
                </def-item>
                <def-item>
                  <term>SRSI</term>
                  <def>
                    <p id="Par12">Self-report scale item</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MAR</term>
                  <def>
                    <p id="Par13">Missing at random</p>
                  </def>
                </def-item>
                <def-item>
                  <term>FIML</term>
                  <def>
                    <p id="Par14">Full-information maximum likelihood</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <fn-group>
              <fn>
                <p>
                  <bold>Publisher’s Note</bold>
                </p>
                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <ack>
              <title>Acknowledgements</title>
              <p>The work was completed while at the Columbia University School of Nursing, New York City, USA.</p>
            </ack>
            <notes notes-type="author-contribution">
              <title>Authors' contributions</title>
              <p>RS and PBC contributed to the conceptualization and design of all aspects of the study. SOR, JJP, and FO contributed to the project administration and resources. MH contributed to the conceptualization, project administration, and resources. SS contributed to the methodology and investigation. HJ designed the proposed data analysis. FO and MB drafted the manuscript. All authors have read and approved the final manuscript.</p>
            </notes>
            <notes notes-type="funding-information">
              <title>Funding</title>
              <p>Research reported in this publication was supported by the Agency for Healthcare Research.</p>
              <p>and Quality (AHRQ) under award number R18HS028523. The content is solely the responsibility of the authors and does not necessarily represent the official views of the AHRQ.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Availability of data and materials</title>
              <p>The datasets generated and/or analyzed during the current study contain sensitive personally identifiable information, including participant’s name and HIV status, and are not publicly available. Study information would be available from the corresponding author upon reasonable request.</p>
            </notes>
            <notes>
              <title>Declarations</title>
              <notes id="FPar1">
                <title>Ethics approval and consent to participate</title>
                <p id="Par35">The study was approved by the Columbia University Institutional Review Board (IRB) and the National Council of Bioethics in Health (Consejo Nacional de Bioética en Salud, CONABIOS) in the Dominican Republic. Study participants provide written informed consent and HIPAA authorization at baseline visits prior to enrollment. Researchers follow institutional policies on data collection and management procedures. Current protocol version: August 15, 2023. Any modifications to the protocol are submitted to and approved by the IRB prior to implementation. Adverse events and unintended effects of the trial are tracked by the study principal investigators and reported to the IRB.</p>
              </notes>
              <notes id="FPar2">
                <title>Consent for publication</title>
                <p id="Par36">Not applicable.</p>
              </notes>
              <notes id="FPar3" notes-type="COI-statement">
                <title>Competing interests</title>
                <p id="Par37">The authors declare no competing interests.</p>
              </notes>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <mixed-citation publication-type="other">Organization WH. <italic>People living with HIV</italic>. 2022; Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/data/gho/data/themes/hiv-aids">https://www.who.int/data/gho/data/themes/hiv-aids</ext-link>.</mixed-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <mixed-citation publication-type="other">CDC. HIV Treatment. 2022; Available from: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/hiv/basics/livingwithhiv/treatment.html">https://www.cdc.gov/hiv/basics/livingwithhiv/treatment.html</ext-link>.</mixed-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <mixed-citation publication-type="other">UNAIDS. Global HIV &amp; AIDS statistics. 2022; Available from: <ext-link ext-link-type="uri" xlink:href="https://www.unaids.org/en/resources/fact-sheet#:~:text=New%20HIV%20infections%20have%20been,4.3%20million%5D%20people%20in%201995">https://www.unaids.org/en/resources/fact-sheet#:~:text=New%20HIV%20infections%20have%20been,4.3%20million%5D%20people%20in%201995</ext-link>.</mixed-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <mixed-citation publication-type="other">CDC. Ending the HIV Epidemic in the U.S. Progress. 2023. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/endhiv/ehe-progress/index.html">https://www.cdc.gov/endhiv/ehe-progress/index.html</ext-link>.</mixed-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <mixed-citation publication-type="other">UNFPA. HIV&amp;AIDS. 2023. Available from: <ext-link ext-link-type="uri" xlink:href="https://caribbean.unfpa.org/en/node/19856">https://caribbean.unfpa.org/en/node/19856</ext-link>.</mixed-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <mixed-citation publication-type="other">UNAIDS. Country Factsheets: Dominican Republic. 2022. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.unaids.org/en/regionscountries/countries/dominicanrepublic">https://www.unaids.org/en/regionscountries/countries/dominicanrepublic</ext-link>.</mixed-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rojas</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The HIV/AIDS epidemic in the Dominican Republic: key contributing factors</article-title>
                  <source>J Int Assoc Physicians AIDS Care</source>
                  <year>2011</year>
                  <volume>10</volume>
                  <issue>5</issue>
                  <fpage>306</fpage>
                  <lpage>315</lpage>
                  <pub-id pub-id-type="doi">10.1177/1545109710397770</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <mixed-citation publication-type="other">Bank TW. Prevalence of HIV, total (% of population ages 15–49) - Latin America &amp; Caribbean. 2021. Available from: <ext-link ext-link-type="uri" xlink:href="https://data.worldbank.org/indicator/SH.DYN.AIDS.ZS?end=2021&amp;locations=ZJ&amp;most_recent_value_desc=true&amp;start=2021&amp;view=map&amp;year=2021">https://data.worldbank.org/indicator/SH.DYN.AIDS.ZS?end=2021&amp;locations=ZJ&amp;most_recent_value_desc=true&amp;start=2021&amp;view=map&amp;year=2021</ext-link>. Cited 2023 08/29/2023.</mixed-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <mixed-citation publication-type="other">Hygiene ND. o.H.a.M., HIV Surveillance Annual Report, 2021. 2021.</mixed-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <mixed-citation publication-type="other">Bureau UC. QuickFacts New York City, New York. 2022. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.census.gov/quickfacts/fact/table/newyorkcitynewyork/PST045222">https://www.census.gov/quickfacts/fact/table/newyorkcitynewyork/PST045222</ext-link>.</mixed-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wallace</surname>
                      <given-names>DD</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The co-management of HIV and chronic non-communicable diseases in the dominican republic: a qualitative study</article-title>
                  <source>PLoS ONE</source>
                  <year>2023</year>
                  <volume>18</volume>
                  <issue>7</issue>
                  <fpage>e0288583</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0288583</pub-id>
                  <?supplied-pmid 37440525?>
                  <pub-id pub-id-type="pmid">37440525</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <mixed-citation publication-type="other">Schnall R, Higgins T, Brown W, Carballo-Dieguez A, Bakken S. Trust, Perceived Risk, Perceived Ease of Use and Perceived Usefulness as Factors Related to mHealth Technology Use. Stud Health Technol Inform. 2015;216:467–71.</mixed-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <mixed-citation publication-type="other">Schnall R, Rojas M, Bakken S, Brown W, Carballo-Dieguez A, Carry M, Gelaude D, Mosley JP, Travers J. A user-centered model for designing consumer mobile health (mHealth) applications (apps). J Biomed Inform. 2016;60:243–51. 10.1016/j.jbi.2016.02.002.</mixed-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stonbraker</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Establishing content for a digital educational support group for new adolescent mothers in the Dominican Republic: a user-centered design approach</article-title>
                  <source>Int J Adolesc Med Health</source>
                  <year>2020</year>
                  <volume>34</volume>
                  <issue>4</issue>
                  <fpage>219</fpage>
                  <lpage>232</lpage>
                  <pub-id pub-id-type="doi">10.1515/ijamh-2020-0054</pub-id>
                  <?supplied-pmid 32857722?>
                  <pub-id pub-id-type="pmid">32857722</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <mixed-citation publication-type="other">Statista. Number of mobile cellular subscriptions in the Dominican Republic from 2000 to 2021. 2023; Available from: <ext-link ext-link-type="uri" xlink:href="https://www.statista.com/statistics/497193/number-of-mobile-cellular-subscriptions-in-dominican-republic/#:~:text=In%202021%2C%20there%20were%20over,penetration%20rate%20of%2087.56%20percent">https://www.statista.com/statistics/497193/number-of-mobile-cellular-subscriptions-in-dominican-republic/#:~:text=In%202021%2C%20there%20were%20over,penetration%20rate%20of%2087.56%20percent</ext-link>.</mixed-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <mixed-citation publication-type="other">Statista. Mobile internet penetration rate in Latin America and the Caribbean as of January 2023, by region. 2023. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.statista.com/statistics/934766/penetration-rate-mobile-internet-latin-america-region/">https://www.statista.com/statistics/934766/penetration-rate-mobile-internet-latin-america-region/</ext-link>.</mixed-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <mixed-citation publication-type="other">Center PR. Mobile phone ownership over time. 2021. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.pewresearch.org/internet/fact-sheet/mobile/">https://www.pewresearch.org/internet/fact-sheet/mobile/</ext-link>.</mixed-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <mixed-citation publication-type="other">International, R. New York City Mobile Services Study. 2023. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.rti.org/impact/new-york-city-mobile-services-study#:~:text=The%20study%20found%20that%2096,is%20higher%20than%20national%20rates">https://www.rti.org/impact/new-york-city-mobile-services-study#:~:text=The%20study%20found%20that%2096,is%20higher%20than%20national%20rates</ext-link>.</mixed-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Beauchemin</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A multi-step usability evaluation of a self-management app to support medication adherence in persons living with HIV</article-title>
                  <source>Int J Med Inform</source>
                  <year>2019</year>
                  <volume>122</volume>
                  <fpage>37</fpage>
                  <lpage>44</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ijmedinf.2018.11.012</pub-id>
                  <?supplied-pmid 30623782?>
                  <pub-id pub-id-type="pmid">30623782</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <mixed-citation publication-type="other">Schnall R, Bakken S, Rojas M, Travers J, Carballo-Dieguez A. mHealth Technology as a Persuasive Tool for Treatment, Care and Management of Persons Living with HIV. AIDS Behav. 2015;19 Suppl 2(0 2):81–9. 10.1007/s10461-014-0984-8.</mixed-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schnall</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Expert Feedback on the adaptation and translation of Spanish version of wiseapp</article-title>
                  <source>Stud Health Technol Inform</source>
                  <year>2023</year>
                  <volume>302</volume>
                  <fpage>500</fpage>
                  <lpage>501</lpage>
                  <?supplied-pmid 37203734?>
                  <pub-id pub-id-type="pmid">37203734</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <mixed-citation publication-type="other">Hahn A, et al. Comparison of evaluation methods for improving the usability of a Spanish mHealth Tool. International Journal of Medical Informatics (under review). 2023.</mixed-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Flynn</surname>
                      <given-names>G</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Protocol of the randomized control trial: the wiseapp trial for improving health outcomes in PLWH (WiseApp)</article-title>
                  <source>BMC Public Health</source>
                  <year>2020</year>
                  <volume>20</volume>
                  <issue>1</issue>
                  <fpage>1775</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12889-020-09688-0</pub-id>
                  <?supplied-pmid 33238931?>
                  <pub-id pub-id-type="pmid">33238931</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wood</surname>
                      <given-names>OR</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A community health worker and mobile health app intervention to improve adherence to HIV medication among persons with HIV: the CHAMPS study protocol</article-title>
                  <source>BMC Public Health</source>
                  <year>2023</year>
                  <volume>23</volume>
                  <issue>1</issue>
                  <fpage>942</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12889-023-15616-9</pub-id>
                  <?supplied-pmid 37226141?>
                  <pub-id pub-id-type="pmid">37226141</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cantisano</surname>
                      <given-names>LM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>ePSICONUT: an e-Health programme to improve emotional health and lifestyle in university students</article-title>
                  <source>Int J Environ Res Public Health</source>
                  <year>2022</year>
                  <volume>19</volume>
                  <issue>15</issue>
                  <fpage>9253</fpage>
                  <pub-id pub-id-type="doi">10.3390/ijerph19159253</pub-id>
                  <?supplied-pmid 35954601?>
                  <pub-id pub-id-type="pmid">35954601</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Muñoz</surname>
                      <given-names>AO</given-names>
                    </name>
                    <name>
                      <surname>Camacho</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Torous</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Marketplace and literature review of Spanish language mental health apps</article-title>
                  <source>Front Digit Health</source>
                  <year>2021</year>
                  <volume>3</volume>
                  <fpage>615366</fpage>
                  <pub-id pub-id-type="doi">10.3389/fdgth.2021.615366</pub-id>
                  <?supplied-pmid 34713093?>
                  <pub-id pub-id-type="pmid">34713093</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <mixed-citation publication-type="other">Goodman LA. Snowball Sampling. Ann Math Stat. 1961;32(1):148–70.</mixed-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Folstein</surname>
                      <given-names>MF</given-names>
                    </name>
                    <name>
                      <surname>Folstein</surname>
                      <given-names>SE</given-names>
                    </name>
                    <name>
                      <surname>McHugh</surname>
                      <given-names>PR</given-names>
                    </name>
                  </person-group>
                  <article-title>Mini-mental state. A practical method for grading the cognitive state of patients for the clinician</article-title>
                  <source>J Psychiatr Res</source>
                  <year>1975</year>
                  <volume>12</volume>
                  <issue>3</issue>
                  <fpage>189</fpage>
                  <lpage>98</lpage>
                  <pub-id pub-id-type="doi">10.1016/0022-3956(75)90026-6</pub-id>
                  <?supplied-pmid 1202204?>
                  <pub-id pub-id-type="pmid">1202204</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Robinson</surname>
                      <given-names>K</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Contamination in complex healthcare trials: the falls in care homes (FinCH) study experience</article-title>
                  <source>BMC Med Res Methodol</source>
                  <year>2020</year>
                  <volume>20</volume>
                  <issue>1</issue>
                  <fpage>46</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12874-020-00925-z</pub-id>
                  <?supplied-pmid 32106827?>
                  <pub-id pub-id-type="pmid">32106827</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schnall</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Mobile health technology for improving symptom management in low income persons living with HIV</article-title>
                  <source>AIDS Behav</source>
                  <year>2018</year>
                  <volume>22</volume>
                  <fpage>3373</fpage>
                  <lpage>3383</lpage>
                  <pub-id pub-id-type="doi">10.1007/s10461-017-2014-0</pub-id>
                  <?supplied-pmid 29299790?>
                  <pub-id pub-id-type="pmid">29299790</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hedden</surname>
                      <given-names>SL</given-names>
                    </name>
                    <name>
                      <surname>Woolson</surname>
                      <given-names>RF</given-names>
                    </name>
                    <name>
                      <surname>Malcolm</surname>
                      <given-names>RJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Randomization in substance abuse clinical trials substance abuse treatment</article-title>
                  <source>Prevention Policy</source>
                  <year>2006</year>
                  <volume>1</volume>
                  <issue>1</issue>
                  <fpage>1</fpage>
                  <lpage>17</lpage>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schnall</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Efficacy of an mHealth self-management intervention for persons living with HIV: the WiseApp randomized clinical trial</article-title>
                  <source>J Am Med Inform Assoc</source>
                  <year>2023</year>
                  <volume>30</volume>
                  <issue>3</issue>
                  <fpage>418</fpage>
                  <lpage>426</lpage>
                  <pub-id pub-id-type="doi">10.1093/jamia/ocac233</pub-id>
                  <?supplied-pmid 36469808?>
                  <pub-id pub-id-type="pmid">36469808</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <mixed-citation publication-type="other">Schnall R, Rojas M, Travers J, Brown W 3rd, Bakken S. Use of Design Science for Informing the Development of a Mobile App for Persons Living with HIV. AMIA Annu Symp Proc. 2014;2014:1037–45.</mixed-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <mixed-citation publication-type="other">Schnall R, Bakken S, Brown Iii W, Carballo-Dieguez A, Iribarren S. Usabilty Evaluation of a Prototype Mobile App for Health Management for Persons Living with HIV. Stud Health Technol Inform. 2016;225:481–5.</mixed-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Justice</surname>
                      <given-names>AC</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Development and validation of a self-completed HIV symptom index</article-title>
                  <source>J Clin Epidemiol</source>
                  <year>2001</year>
                  <volume>54</volume>
                  <issue>Suppl 1</issue>
                  <fpage>S77</fpage>
                  <lpage>90</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0895-4356(01)00449-8</pub-id>
                  <?supplied-pmid 11750213?>
                  <pub-id pub-id-type="pmid">11750213</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bakken</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Relationships between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV/AIDS</article-title>
                  <source>AIDS Patient Care STDS</source>
                  <year>2000</year>
                  <volume>14</volume>
                  <issue>4</issue>
                  <fpage>189</fpage>
                  <lpage>197</lpage>
                  <pub-id pub-id-type="doi">10.1089/108729100317795</pub-id>
                  <?supplied-pmid 10806637?>
                  <pub-id pub-id-type="pmid">10806637</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Earnshaw</surname>
                      <given-names>VA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>HIV stigma mechanisms and well-being among PLWH: a test of the HIV stigma framework</article-title>
                  <source>AIDS Behav</source>
                  <year>2013</year>
                  <volume>17</volume>
                  <issue>5</issue>
                  <fpage>1785</fpage>
                  <lpage>1795</lpage>
                  <pub-id pub-id-type="doi">10.1007/s10461-013-0437-9</pub-id>
                  <?supplied-pmid 23456594?>
                  <pub-id pub-id-type="pmid">23456594</pub-id>
                </element-citation>
              </ref>
              <ref id="CR38">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Curran</surname>
                      <given-names>GM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact</article-title>
                  <source>Med Care</source>
                  <year>2012</year>
                  <volume>50</volume>
                  <issue>3</issue>
                  <fpage>217</fpage>
                  <lpage>226</lpage>
                  <pub-id pub-id-type="doi">10.1097/MLR.0b013e3182408812</pub-id>
                  <?supplied-pmid 22310560?>
                  <pub-id pub-id-type="pmid">22310560</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Beck</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Steer</surname>
                      <given-names>RA</given-names>
                    </name>
                    <name>
                      <surname>Carbin</surname>
                      <given-names>MG</given-names>
                    </name>
                  </person-group>
                  <article-title>Psychometric properties of the beck depression inventory: twenty-five years of evaluation</article-title>
                  <source>Clin Psychol Rev</source>
                  <year>1988</year>
                  <volume>8</volume>
                  <issue>1</issue>
                  <fpage>77</fpage>
                  <lpage>100</lpage>
                  <pub-id pub-id-type="doi">10.1016/0272-7358(88)90050-5</pub-id>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Naar-King</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Psychosocial factors and medication adherence in HIV-positive youth</article-title>
                  <source>AIDS Patient Care STDS</source>
                  <year>2006</year>
                  <volume>20</volume>
                  <issue>1</issue>
                  <fpage>44</fpage>
                  <lpage>47</lpage>
                  <pub-id pub-id-type="doi">10.1089/apc.2006.20.44</pub-id>
                  <?supplied-pmid 16426155?>
                  <pub-id pub-id-type="pmid">16426155</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nugent</surname>
                      <given-names>NR</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Youth living with HIV and problem substance use: elevated distress is associated with nonadherence and sexual risk</article-title>
                  <source>J Int Assoc Physicians AIDS Care (Chic)</source>
                  <year>2010</year>
                  <volume>9</volume>
                  <issue>2</issue>
                  <fpage>113</fpage>
                  <lpage>115</lpage>
                  <pub-id pub-id-type="doi">10.1177/1545109709357472</pub-id>
                  <?supplied-pmid 20133498?>
                  <pub-id pub-id-type="pmid">20133498</pub-id>
                </element-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <mixed-citation publication-type="other">Derogatis LR. BSI brief symptom inventory: Administration, scoring and procedures manual. 4th ed. Mineapolis: National Computer Systems; 1993.</mixed-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Feldman</surname>
                      <given-names>BJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV</article-title>
                  <source>AIDS Behav</source>
                  <year>2013</year>
                  <volume>17</volume>
                  <fpage>307</fpage>
                  <lpage>318</lpage>
                  <pub-id pub-id-type="doi">10.1007/s10461-012-0326-7</pub-id>
                  <?supplied-pmid 23108721?>
                  <pub-id pub-id-type="pmid">23108721</pub-id>
                </element-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <collab>Use C. f.M.P.f.H, C.f.M.P.f.H. Use</collab>
                  </person-group>
                  <source>Guideline on adjustment for baseline covariates in clinical trials</source>
                  <year>2015</year>
                  <publisher-loc>London</publisher-loc>
                  <publisher-name>European Medicines Agency</publisher-name>
                </element-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <mixed-citation publication-type="other">Little RJ, Rubin DB. Statistical analysis with missing data. Volume 793. Hoboken: Wiley; 2019.</mixed-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Carpenter</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Pocock</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Johan Lamm</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Coping with missing data in clinical trials: a model-based approach applied to Asthma trials</article-title>
                  <source>Stat Med</source>
                  <year>2002</year>
                  <volume>21</volume>
                  <issue>8</issue>
                  <fpage>1043</fpage>
                  <lpage>66</lpage>
                  <pub-id pub-id-type="doi">10.1002/sim.1065</pub-id>
                  <?supplied-pmid 11933033?>
                  <pub-id pub-id-type="pmid">11933033</pub-id>
                </element-citation>
              </ref>
              <ref id="CR47">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Liu</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Waternaux</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Petkova</surname>
                      <given-names>E</given-names>
                    </name>
                  </person-group>
                  <article-title>Influence of human immunodeficiency virus Infection on neurological impairment: an analysis of longitudinal binary data with informative drop-out</article-title>
                  <source>J Royal Stat Soc Ser C</source>
                  <year>1999</year>
                  <volume>48</volume>
                  <issue>1</issue>
                  <fpage>103</fpage>
                  <lpage>115</lpage>
                  <pub-id pub-id-type="doi">10.1111/1467-9876.00143</pub-id>
                </element-citation>
              </ref>
              <ref id="CR48">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Diggle</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Kenward</surname>
                      <given-names>MG</given-names>
                    </name>
                  </person-group>
                  <article-title>Informative drop-out in longitudinal data analysis</article-title>
                  <source>J Royal Stat Soc Ser C: Appl Stat</source>
                  <year>1994</year>
                  <volume>43</volume>
                  <issue>1</issue>
                  <fpage>49</fpage>
                  <lpage>73</lpage>
                </element-citation>
              </ref>
              <ref id="CR49">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lachin</surname>
                      <given-names>JM</given-names>
                    </name>
                  </person-group>
                  <article-title>Statistical considerations in the intent-to-treat principle</article-title>
                  <source>Control Clin Trials</source>
                  <year>2000</year>
                  <volume>21</volume>
                  <issue>3</issue>
                  <fpage>167</fpage>
                  <lpage>189</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0197-2456(00)00046-5</pub-id>
                  <?supplied-pmid 10822117?>
                  <pub-id pub-id-type="pmid">10822117</pub-id>
                </element-citation>
              </ref>
              <ref id="CR50">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Guaraldi</surname>
                      <given-names>G</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Aging with HIV vs. HIV seroconversion at older age: a diverse population with distinct comorbidity profiles</article-title>
                  <source>PLoS ONE</source>
                  <year>2015</year>
                  <volume>10</volume>
                  <issue>4</issue>
                  <fpage>e0118531</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0118531</pub-id>
                  <?supplied-pmid 25874806?>
                  <pub-id pub-id-type="pmid">25874806</pub-id>
                </element-citation>
              </ref>
              <ref id="CR51">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Miners</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population</article-title>
                  <source>The Lancet HIV</source>
                  <year>2014</year>
                  <volume>1</volume>
                  <issue>1</issue>
                  <fpage>e32</fpage>
                  <lpage>e40</lpage>
                  <pub-id pub-id-type="doi">10.1016/S2352-3018(14)70018-9</pub-id>
                  <?supplied-pmid 26423814?>
                  <pub-id pub-id-type="pmid">26423814</pub-id>
                </element-citation>
              </ref>
              <ref id="CR52">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jia</surname>
                      <given-names>H</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A further investigation of health-related quality of life over time among men with HIV Infection in the HAART era</article-title>
                  <source>Qual Life Res</source>
                  <year>2007</year>
                  <volume>16</volume>
                  <fpage>961</fpage>
                  <lpage>968</lpage>
                  <pub-id pub-id-type="doi">10.1007/s11136-007-9214-4</pub-id>
                  <?supplied-pmid 17468942?>
                  <pub-id pub-id-type="pmid">17468942</pub-id>
                </element-citation>
              </ref>
              <ref id="CR53">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Amico</surname>
                      <given-names>KR</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Randomized controlled trial of a remote coaching mHealth adherence intervention in Youth living with HIV</article-title>
                  <source>AIDS Behav</source>
                  <year>2022</year>
                  <volume>26</volume>
                  <issue>12</issue>
                  <fpage>3897</fpage>
                  <lpage>3913</lpage>
                  <pub-id pub-id-type="doi">10.1007/s10461-022-03717-2</pub-id>
                  <?supplied-pmid 35670987?>
                  <pub-id pub-id-type="pmid">35670987</pub-id>
                </element-citation>
              </ref>
              <ref id="CR54">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jones</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Leveraging mHealth and patient supporters for African americans’ and Latinxs’ Engagement in HIV Care (LEAN): protocol for a Randomized, controlled, effectiveness-implementation trial</article-title>
                  <source>JMIR Res Protoc</source>
                  <year>2023</year>
                  <volume>12</volume>
                  <fpage>e42691</fpage>
                  <pub-id pub-id-type="doi">10.2196/42691</pub-id>
                  <?supplied-pmid 36787165?>
                  <pub-id pub-id-type="pmid">36787165</pub-id>
                </element-citation>
              </ref>
              <ref id="CR55">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Navarra</surname>
                      <given-names>AD</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Feasibility and acceptability of the adherence connection counseling, Education, and support (ACCESS) proof of Concept: a Peer-Led, Mobile Health (mHealth) cognitive behavioral antiretroviral therapy (ART) adherence intervention for HIV-Infected (HIV+) adolescents and young adults (AYA)</article-title>
                  <source>AIDS Behav</source>
                  <year>2023</year>
                  <volume>27</volume>
                  <issue>6</issue>
                  <fpage>1807</fpage>
                  <lpage>1823</lpage>
                  <pub-id pub-id-type="doi">10.1007/s10461-022-03913-0</pub-id>
                  <?supplied-pmid 36574184?>
                  <pub-id pub-id-type="pmid">36574184</pub-id>
                </element-citation>
              </ref>
              <ref id="CR56">
                <label>56.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ranjit</surname>
                      <given-names>YS</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>mHealth intervention to Improve Treatment outcomes among people with HIV who Use Cocaine: protocol for a pilot randomized controlled trial</article-title>
                  <source>JMIR Res Protoc</source>
                  <year>2022</year>
                  <volume>11</volume>
                  <issue>3</issue>
                  <fpage>e28332</fpage>
                  <pub-id pub-id-type="doi">10.2196/28332</pub-id>
                  <?supplied-pmid 35254270?>
                  <pub-id pub-id-type="pmid">35254270</pub-id>
                </element-citation>
              </ref>
              <ref id="CR57">
                <label>57.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Saberi</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Exploration of a mobile technology vulnerability scale’s association with antiretroviral adherence among young adults living with HIV in the United States</article-title>
                  <source>Mhealth</source>
                  <year>2022</year>
                  <volume>8</volume>
                  <fpage>23</fpage>
                  <pub-id pub-id-type="doi">10.21037/mhealth-21-54</pub-id>
                  <?supplied-pmid 35928514?>
                  <pub-id pub-id-type="pmid">35928514</pub-id>
                </element-citation>
              </ref>
              <ref id="CR58">
                <label>58.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sun</surname>
                      <given-names>CJ</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Virtual voices: examining social support exchanged through participant-generated and unmoderated content in a mobile intervention to improve HIV antiretroviral therapy adherence among GBMSM</article-title>
                  <source>AIDS Care</source>
                  <year>2023</year>
                  <volume>35</volume>
                  <issue>1</issue>
                  <fpage>7</fpage>
                  <lpage>15</lpage>
                  <pub-id pub-id-type="doi">10.1080/09540121.2022.2038364</pub-id>
                  <?supplied-pmid 35156485?>
                  <pub-id pub-id-type="pmid">35156485</pub-id>
                </element-citation>
              </ref>
              <ref id="CR59">
                <label>59.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sun</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effectiveness of mHealth on adherence to antiretroviral therapy in patients living with HIV: meta-analysis of randomized controlled trials</article-title>
                  <source>JMIR Mhealth Uhealth</source>
                  <year>2023</year>
                  <volume>11</volume>
                  <fpage>e42799</fpage>
                  <pub-id pub-id-type="doi">10.2196/42799</pub-id>
                  <?supplied-pmid 36689267?>
                  <pub-id pub-id-type="pmid">36689267</pub-id>
                </element-citation>
              </ref>
              <ref id="CR60">
                <label>60.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ramsey</surname>
                      <given-names>SE</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A preliminary test of an mHealth facilitated health coaching intervention to improve medication adherence among persons living with HIV</article-title>
                  <source>AIDS Behav</source>
                  <year>2021</year>
                  <volume>25</volume>
                  <issue>11</issue>
                  <fpage>3782</fpage>
                  <lpage>3797</lpage>
                  <pub-id pub-id-type="doi">10.1007/s10461-021-03342-5</pub-id>
                  <?supplied-pmid 34117965?>
                  <pub-id pub-id-type="pmid">34117965</pub-id>
                </element-citation>
              </ref>
              <ref id="CR61">
                <label>61.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Saberi</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A Mobile Health App (WYZ) for engagement in care and antiretroviral therapy adherence among youth and young adults living with HIV: single-arm pilot intervention study</article-title>
                  <source>JMIR Form Res</source>
                  <year>2021</year>
                  <volume>5</volume>
                  <issue>8</issue>
                  <fpage>e26861</fpage>
                  <pub-id pub-id-type="doi">10.2196/26861</pub-id>
                  <?supplied-pmid 34463622?>
                  <pub-id pub-id-type="pmid">34463622</pub-id>
                </element-citation>
              </ref>
              <ref id="CR62">
                <label>62.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>DeFulio</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Smartphone-based incentives for promoting adherence to antiretroviral therapy: a randomized controlled trial</article-title>
                  <source>Prev Med Rep</source>
                  <year>2021</year>
                  <volume>21</volume>
                  <fpage>101318</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.pmedr.2021.101318</pub-id>
                  <?supplied-pmid 33511028?>
                  <pub-id pub-id-type="pmid">33511028</pub-id>
                </element-citation>
              </ref>
              <ref id="CR63">
                <label>63.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Duthely</surname>
                      <given-names>LM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A multilingual, culturally competent Mobile Health intervention to improve treatment adherence among women living with HIV: protocol for a Randomized Controlled Trial</article-title>
                  <source>JMIR Res Protoc</source>
                  <year>2020</year>
                  <volume>9</volume>
                  <issue>6</issue>
                  <fpage>e17656</fpage>
                  <pub-id pub-id-type="doi">10.2196/17656</pub-id>
                  <?supplied-pmid 32438338?>
                  <pub-id pub-id-type="pmid">32438338</pub-id>
                </element-citation>
              </ref>
              <ref id="CR64">
                <label>64.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ventuneac</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A mobile health intervention in HIV primary care: supporting patients at risk for ART non-adherence</article-title>
                  <source>HIV Res Clin Pract</source>
                  <year>2020</year>
                  <volume>21</volume>
                  <issue>5</issue>
                  <fpage>140</fpage>
                  <lpage>150</lpage>
                  <pub-id pub-id-type="doi">10.1080/25787489.2020.1862972</pub-id>
                  <?supplied-pmid 33369547?>
                  <pub-id pub-id-type="pmid">33369547</pub-id>
                </element-citation>
              </ref>
              <ref id="CR65">
                <label>65.</label>
                <mixed-citation publication-type="other">Schnall R, Mosley JP, Iribarren SJ, Bakken S, Carballo-Diéguez A, Brown Iii W. Comparison of a User-Centered Design, Self-Management App to Existing mHealth Apps for Persons Living With HIV. JMIR Mhealth Uhealth. 2015;3(3):e91. 10.2196/mhealth.4882.</mixed-citation>
              </ref>
              <ref id="CR66">
                <label>66.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Aunon</surname>
                      <given-names>FM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Randomized controlled trial of a theory-informed mHealth intervention to support ART adherence and viral suppression among women with HIV in Mombasa, Kenya: preliminary efficacy and participant-level feasibility and acceptability</article-title>
                  <source>BMC Public Health</source>
                  <year>2023</year>
                  <volume>23</volume>
                  <issue>1</issue>
                  <fpage>837</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12889-023-15638-3</pub-id>
                  <?supplied-pmid 37158872?>
                  <pub-id pub-id-type="pmid">37158872</pub-id>
                </element-citation>
              </ref>
              <ref id="CR67">
                <label>67.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mulawa</surname>
                      <given-names>MI</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Supporting adolescents with HIV in South Africa through an adherence-supporting app: mixed methods Beta-testing study</article-title>
                  <source>JMIR Form Res</source>
                  <year>2023</year>
                  <volume>7</volume>
                  <fpage>e47575</fpage>
                  <pub-id pub-id-type="doi">10.2196/47575</pub-id>
                  <?supplied-pmid 37261883?>
                  <pub-id pub-id-type="pmid">37261883</pub-id>
                </element-citation>
              </ref>
              <ref id="CR68">
                <label>68.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Naggirinya</surname>
                      <given-names>AB</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Willingness to pay for an mHealth anti-retroviral therapy adherence and information tool: transitioning to sustainability, call for life randomised study experience in Uganda</article-title>
                  <source>BMC Med Inform Decis Mak</source>
                  <year>2022</year>
                  <volume>22</volume>
                  <issue>1</issue>
                  <fpage>52</fpage>
                  <pub-id pub-id-type="doi">10.1186/s12911-022-01782-0</pub-id>
                  <?supplied-pmid 35219309?>
                  <pub-id pub-id-type="pmid">35219309</pub-id>
                </element-citation>
              </ref>
              <ref id="CR69">
                <label>69.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>O’Connor</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Delivering an mHealth Adherence Support intervention for patients with HIV: mixed methods process evaluation of the Philippines Connect for Life Study</article-title>
                  <source>JMIR Form Res</source>
                  <year>2022</year>
                  <volume>6</volume>
                  <issue>8</issue>
                  <fpage>e37163</fpage>
                  <pub-id pub-id-type="doi">10.2196/37163</pub-id>
                  <?supplied-pmid 35969425?>
                  <pub-id pub-id-type="pmid">35969425</pub-id>
                </element-citation>
              </ref>
              <ref id="CR70">
                <label>70.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tran</surname>
                      <given-names>BX</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Efficacy of a Mobile Phone-Based Intervention on Health Behaviors and HIV/AIDS Treatment Management: Randomized Controlled Trial</article-title>
                  <source>J Med Internet Res</source>
                  <year>2023</year>
                  <volume>25</volume>
                  <fpage>e43432</fpage>
                  <pub-id pub-id-type="doi">10.2196/43432</pub-id>
                  <?supplied-pmid 37104001?>
                  <pub-id pub-id-type="pmid">37104001</pub-id>
                </element-citation>
              </ref>
              <ref id="CR71">
                <label>71.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ameli</surname>
                      <given-names>V</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Tailored mHealth intervention for improving treatment adherence for people living with HIV in Iran (HamRaah): protocol for a feasibility study and randomised pilot trial with a nested realist evaluation</article-title>
                  <source>BMJ Open</source>
                  <year>2021</year>
                  <volume>11</volume>
                  <issue>6</issue>
                  <fpage>e042296</fpage>
                  <pub-id pub-id-type="doi">10.1136/bmjopen-2020-042296</pub-id>
                  <?supplied-pmid 34162631?>
                  <pub-id pub-id-type="pmid">34162631</pub-id>
                </element-citation>
              </ref>
              <ref id="CR72">
                <label>72.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chory</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A pilot study of a mobile intervention to support mental health and adherence among adolescents living with HIV in Western Kenya</article-title>
                  <source>AIDS Behav</source>
                  <year>2022</year>
                  <volume>26</volume>
                  <issue>1</issue>
                  <fpage>232</fpage>
                  <lpage>242</lpage>
                  <pub-id pub-id-type="doi">10.1007/s10461-021-03376-9</pub-id>
                  <?supplied-pmid 34292429?>
                  <pub-id pub-id-type="pmid">34292429</pub-id>
                </element-citation>
              </ref>
              <ref id="CR73">
                <label>73.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>O’Connor</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Interactive mobile phone HIV adherence support for men who have sex with men in the philippines connect for life study: mixed methods approach to intervention development and pilot testing</article-title>
                  <source>JMIR Form Res</source>
                  <year>2022</year>
                  <volume>6</volume>
                  <issue>2</issue>
                  <fpage>e30811</fpage>
                  <pub-id pub-id-type="doi">10.2196/30811</pub-id>
                  <?supplied-pmid 35113030?>
                  <pub-id pub-id-type="pmid">35113030</pub-id>
                </element-citation>
              </ref>
              <ref id="CR74">
                <label>74.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Twimukye</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Acceptability of a mobile phone support tool (call for Life Uganda) for promoting adherence to antiretroviral therapy among young adults in a randomized controlled trial: exploratory qualitative study</article-title>
                  <source>JMIR Mhealth Uhealth</source>
                  <year>2021</year>
                  <volume>9</volume>
                  <issue>6</issue>
                  <fpage>e17418</fpage>
                  <pub-id pub-id-type="doi">10.2196/17418</pub-id>
                  <?supplied-pmid 34121665?>
                  <pub-id pub-id-type="pmid">34121665</pub-id>
                </element-citation>
              </ref>
              <ref id="CR75">
                <label>75.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ahonkhai</surname>
                      <given-names>AA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>PEERNaija: a gamified mHealth behavioral intervention to improve adherence to antiretroviral treatment among adolescents and young adults in Nigeria. Front</article-title>
                  <source>Reprod Health</source>
                  <year>2021</year>
                  <volume>3</volume>
                  <fpage> 656507</fpage>
                </element-citation>
              </ref>
              <ref id="CR76">
                <label>76.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Krishnan</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Assessing mobile technology use and mHealth acceptance among HIV-positive men who have sex with men and transgender women in Malaysia</article-title>
                  <source>PLoS ONE</source>
                  <year>2021</year>
                  <volume>16</volume>
                  <issue>3</issue>
                  <fpage>e0248705</fpage>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0248705</pub-id>
                  <?supplied-pmid 33755693?>
                  <pub-id pub-id-type="pmid">33755693</pub-id>
                </element-citation>
              </ref>
              <ref id="CR77">
                <label>77.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McCreesh-Toselli</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Staff perceptions of preimplementation barriers and facilitators to a mobile health antiretroviral therapy adherence counseling intervention in South Africa: qualitative study</article-title>
                  <source>JMIR Mhealth Uhealth</source>
                  <year>2021</year>
                  <volume>9</volume>
                  <issue>4</issue>
                  <fpage>e23280</fpage>
                  <pub-id pub-id-type="doi">10.2196/23280</pub-id>
                  <?supplied-pmid 33821806?>
                  <pub-id pub-id-type="pmid">33821806</pub-id>
                </element-citation>
              </ref>
              <ref id="CR78">
                <label>78.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Barrington</surname>
                      <given-names>C</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>I’ve learned to Value myself more: piloting an adapted multilevel intervention for transgender women sex workers living with HIV in the dominican republic</article-title>
                  <source>Transgend Health</source>
                  <year>2021</year>
                  <volume>6</volume>
                  <issue>3</issue>
                  <fpage>148</fpage>
                  <lpage>155</lpage>
                  <pub-id pub-id-type="doi">10.1089/trgh.2020.0058</pub-id>
                  <?supplied-pmid 34414270?>
                  <pub-id pub-id-type="pmid">34414270</pub-id>
                </element-citation>
              </ref>
              <ref id="CR79">
                <label>79.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Budhwani</surname>
                      <given-names>H</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Adapting and pilot testing an HIV and intersectional stigma reducing intervention for Dominican Republic healthcare contexts: protocol for translational research</article-title>
                  <source>Contemp Clin Trials Commun</source>
                  <year>2022</year>
                  <volume>29</volume>
                  <fpage>100980</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.conctc.2022.100980</pub-id>
                  <?supplied-pmid 36060154?>
                  <pub-id pub-id-type="pmid">36060154</pub-id>
                </element-citation>
              </ref>
              <ref id="CR80">
                <label>80.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Derose</surname>
                      <given-names>KP</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Developing Pilot interventions to address Food Insecurity and Nutritional needs of people living with HIV in Latin America and the Caribbean: an Interinstitutional Approach using Formative Research</article-title>
                  <source>Food Nutr Bull</source>
                  <year>2018</year>
                  <volume>39</volume>
                  <issue>4</issue>
                  <fpage>549</fpage>
                  <lpage>563</lpage>
                  <pub-id pub-id-type="doi">10.1177/0379572118809302</pub-id>
                  <?supplied-pmid 30453759?>
                  <pub-id pub-id-type="pmid">30453759</pub-id>
                </element-citation>
              </ref>
              <ref id="CR81">
                <label>81.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nwaozuru</surname>
                      <given-names>U</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Mobile health interventions for HIV/STI prevention among youth in low- and middle-income countries (LMICs): a systematic review of studies reporting implementation outcomes</article-title>
                  <source>Implement Sci Commun</source>
                  <year>2021</year>
                  <volume>2</volume>
                  <issue>1</issue>
                  <fpage>126</fpage>
                  <pub-id pub-id-type="doi">10.1186/s43058-021-00230-w</pub-id>
                  <?supplied-pmid 34742357?>
                  <pub-id pub-id-type="pmid">34742357</pub-id>
                </element-citation>
              </ref>
              <ref id="CR82">
                <label>82.</label>
                <mixed-citation publication-type="other">Project HFG. Treatment for All Strategy for HIV Adopted in the Dominican Republic. 2020; Available from: <ext-link ext-link-type="uri" xlink:href="https://www.hfgproject.org/treatment-for-all-strategy-for-hiv-adopted-in-the-dominican-republic/">https://www.hfgproject.org/treatment-for-all-strategy-for-hiv-adopted-in-the-dominican-republic/</ext-link>.</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
